MLNT - Melinta Therapeutics' (MLNT) CEO John Johnson on Q1 2019 Results - Earnings Call Transcript
Melinta Therapeutics, Inc. (MLNT)
Q1 2019 Earnings Conference Call
May 9, 2019 4:30 PM ET
Company Participants
Susan Blum – Vice President-Finance and Chief Accounting Officer
John Johnson – Chief Executive Officer
Tim Simon – Chief Commercial Officer
Peter Milligan – Chief Financial Officer
Conference Call Participants
Sudan Loganathan – Cantor Fitzgerald
David Hoang – Jefferies
Kevin Kedra – G. Research
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to the Melinta Therapeutics First Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like